(688366)"Shanghai Haohai Biological Technology Co., Ltd."Report for Q3 2026
Filed with SSE · Stock code 688366 · · 9 pages · Chinese
Summary by 6ix AI
It also highlights the company's commitment to the accuracy and completeness of the report's content, ensuring no misleading statements are present. Additionally, the report addresses changes in financial indicators and provides insights into non-recurring profit and loss items.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Shanghai Haohai Biological Technology Co., Ltd. on 6ix
Earlier from Shanghai Haohai Biological Technology
- Announcement on Adjustment of the Total Cash Dividend Amount for the 2026 Semi-annual Profit Distribution
- Announcement on Participating in the 2026 Semi-annual Collective Performance Briefing for the STAR Market Biological Products and CXO Industry
- Announcement on the Profit Distribution Plan for the First Half of 2026
- Announcement on Voluntary Disclosure of Obtaining Medical Device Registration Certificate for Trifocal Toric Intraocular Lens Product of the Controlled Subsidiary
- Announcement on the Cancellation of Repurchased H Shares
Later from Shanghai Haohai Biological Technology
All Shanghai Haohai Biological Technology news releasesFollow Shanghai Haohai Biological Technology into a list and get an email when it puts out news.
Follow Shanghai Haohai Biological Technology